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ess: jon.hardie@med.uSummary Study question: What is the prevalence of respiratory symptoms and
obstructive pulmonary disease by age, sex, and smoking history in a population aged
70 years and older? What is the association between selected comorbidities and
obstructive pulmonary disease?
Patients and methods: A questionnaire on respiratory symptoms and disease,
selected comorbidities, and smoking history was mailed to a cross-sectional, sex-
and age-stratified, random sample of the population 70 years and older of Bergen,
Norway.
Results: About 11% of these elderly persons reported having at least one current
obstructive pulmonary disease, 8% reported daily wheezing, and 12% reported
significant dyspnea. The only respiratory symptom or disorder to show any clear age-
related pattern was dyspnea, which increased through age 89 before declining.
Dyspnea, current asthma, and current chronic bronchitis were about half as likely in
males as females, after adjusting for smoking pack-years. Persons with obstructive
pulmonary disease reported problems with walking, heart disease, and muscle/joint
disease more frequently than those without.
Conclusions: The prevalence of respiratory symptoms and obstructive pulmonary
disease has been estimated. Only dyspnea was associated with age in this elderly
population. Female sex was a predictor of dyspnea, current asthma, and current
chronic bronchitis.
r 2004 Elsevier Ltd. All rights reserved.4 Elsevier Ltd. All rights reserved.
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The elderly portion of the population is growing
worldwide.1 Ten percent of the world population
was over age 60 in 1999, and it is predicted that in
2050 this percentage will have grown to 22%. In
epidemiological studies on respiratory health, the
portion of the population over age 70 generally has
been treated as a homogeneous group and repre-
sented as one or two age groups at the high end of
the age spectrum. Studies based on random
population samples in this age group often end up
having very few of the ‘‘oldest old’’ in the sample,
making analysis by age difficult.2–5 Little attention
has been given to how respiratory symptoms and
disease prevalence vary by sex, age, and smoking
status within this age group. How much variation is
due to sex and how continued aging affects the
respiratory health of this portion of the population
are unknown.
In Norway, Langhammer and colleagues6 recently
reported prevalence data in an aged population on
a limited set of respiratory symptoms (wheezing,
cough, and phlegm) and disorders (asthma and
chronic bronchitis). In England, Dow and collea-
gues2 performed a mailed questionnaire survey of
persons 65 years and older to identify patterns of
symptoms that might identify bronchial irritability
in elderly persons. Horsley and colleagues3 also
reported the prevalence of certain respiratory
symptoms and obstructive pulmonary diseases
(OPD) in the population 65 years, and over but
did not analyze the effect of continued aging or
variation by sex.
In the US, the Cardiovascular Health Study4 (CHS)
described the respiratory symptoms and disease
prevalence of elderly persons (age 65+ years) in the
cohort at baseline. Institutionalized persons, per-
sons with terminal illness, those with inability to
walk or communicate, and persons likely to
move away were all excluded from the cohort
prior to this analysis. Mannino and colleagues
reported the prevalence of OPD based on data
from the National Health and Nutrition Exami-
nation Study (NHANES). Respiratory symptoms were
reported by race and OPD diagnosis but not by sex
or age.5
The presence of non-respiratory disease condi-
tions is also common in this age group. Limited data
are available on the distribution of these conditions
among those with and without OPD.7
In this paper, we describe the prevalence of
respiratory symptoms and obstructive pulmonary
disease by age, sex, and smoking history in the
population 70 years and older in Bergen, Norway.
We also report the prevalence of selected comor-bidities and the associations between these comor-
bidities and OPD.Material and methods
Study subjects
The study was performed in the city of Bergen, on
the western coast of Norway. According to the
central population registry, the Bergen population
aged470 years was 25,997 at the start of the study
(November 30, 1998). From these subjects, an age-
and sex-stratified random sample was drawn,
consisting of 107 persons of each sex for each 2-
year age group. For males over 95 years and
females over 97 years, there were fewer than 107
people per 2-year age group in Bergen so the whole
population was sampled. The total initial sample
was 2871 persons. There were 1649 responses to
the mailed questionnaire survey (56% crude re-
sponse rate). Response to the questionnaire was
poorer for women than for men and decreased by
increasing age, falling to below 50% at about age 85
years for females and age 90 years for males. The
overall response rate adjusted to the age and sex
make up of the population would be 65.4%.
Study design
This study was cross-sectional by design. The
mailed questionnaire survey was the first stage of
a two-stage study, with the ultimate goal of
establishing reference values for arterial blood
gases in the elderly population. To accomplish this,
we needed ample numbers of never-smokers in all
age groups. To ensure a sufficient number of the
oldest old, an age- and sex-stratified sample was
used. The number of women and men sampled
within each 2-year age cohort was a result of
estimating never-smoker prevalence.8
Methods
Questionnaire: A seven-page questionnaire that
asked about respiratory symptoms and disease
and comorbidities was mailed in December 1998
and January 1999. The questionnaire was a trans-
lated (from English into Norwegian) version of the
original ATS-DLD-78questionnaire.9 Topics and
questions analyzed in this study are described in
detail in the appendix. The variable ‘‘At least one
OPD’’ was defined as an affirmative answer to
at least one of questions on doctor-diagnosed
asthma, chronic bronchitis, or emphysema. The
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Table 1 Demographic and smoking data of the
sample.
Men Women
n ¼ 848 n ¼ 801
Age groups (n)
J.A. Hardie et al.188variable ‘‘dyspnea grade 3’’ represents ‘‘ever
having to stop for breath when walking at your
own pace on the level’’. The variable ‘‘Chronic
Phlegm’’ was defined as bringing up phlegm on most
days, for 3 consecutive months or more during the
year, for at least the past 2 years.70–74 years 196 177
75–79 years 214 213
80–84 years 175 133
85–89 years 163 131
90–94 years 86 93
95 þ years 14 54
Smoking history
Never-smokes (%) 26.3 68.3
Ex-smokers (%) 59.1 21.5
Current-smokers (%) 14.6 10.2
Ex-smoker pack-
years (mean (SD))
22.7(20.8) 13.0(12.3)
Current-smoker
pack-years (mean(SD))
37.5(19.2) 24.9(15.3)
Missing data: 36 on smoking history, 54 of 201 on current
smokers pack-years, 129 of 661 on ex-smokers pack-years.Analysis
Population prevalence results were calculated by
weighting each study subject in their respective sex
and 2-year age stratum for the city of Bergen at the
time of sampling. The variances of the prevalence
estimates in smoking history sub-groups were not
calculated, although significance testing for the
prevalence differences in the smoking history sub-
groups was performed using logistic regression,
adjusting for age and sex.
Logistic regression analysis was performed en-
tering all of the main variables (sex, smoking status
or pack-years and age) in one step. Thereafter,
both second-order (with all main and first-order
interaction terms entered in the base model) and
first-order interactions (with all main variables in
the base model) were tested in a forward stepwise
fashion with the likelihood-ratio test.
All statistical calculations were performed using
SPSS 9.0 (SPSS Inc, Chicago, Illinois, USA).
The study was reviewed and approved by the
Western Norway regional committee on medical
research ethics.Results
The demographic and smoking history data of the
sample are presented in Table 1. Due to small
numbers, the age 90–94 and age 95+ groups are
combined in subsequent analyses.
Population prevalence estimates adjusted for the
age and sex distribution of the population of Bergen
are presented in Table 2. In the population, the
prevalence of respiratory symptoms was higher in
men, with the exception of dyspnea grade 3. OPD
prevalence was higher for men with the exception
of current asthma, which was close to equally
prevalent in both sexes.
The obstructive pulmonary diseases showed
considerable overlap. Of the subjects reporting
current asthma, 36% also reported current chronic
bronchitis, and 23% reported emphysema. Of those
reporting current chronic bronchitis, 33% also
reported emphysema, and 67% reported current
asthma. Of those reporting emphysema, 30% alsoreported current chronic bronchitis, and 37%
reported current asthma.
The frequency of respiratory symptoms and
obstructive lung disease as seen in 5-year age
groups (merging the age groups over age 90) is
shown in Fig. 1. The only respiratory symptom or
disorder to show any clear age-related pattern was
dyspnea, which increased through age 89 before
declining somewhat.
There were far more female never-smokers than
male never-smokers in all age groups, as shown in
Fig. 2a and b. Among females, the frequency of
never-smokers increased consistently by age. As
seen in Table 1, male ex- and current smokers have
significantly higher number of pack-years than do
female ex- and current smokers. The mean age of
current smokers was lower than ex-smokers, which
was lower than never-smokers (78.6, 80.6, and 82.8
years, respectively; Po0:001). Similar results were
seen for males and females.
Cough, phlegm, and wheeze prevalence increased
consistently by smoking history (never-smokero ex-
smoker o current smoker), with the exception of
wheeze in female smokers, where current smokers
had a lower prevalence of wheeze than ex-smokers
(Table 3). Dyspnea grade 3 was most prevalent in ex-
smokers, followed by current smokers.
The prevalence of doctor-diagnosed obstructive
pulmonary disease (asthma, chronic bronchitis, and
emphysema) increased significantly by smoking
history (Table 3).
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Figure 1 Respiratory symptoms and obstructive pulmonary disease by age in 5-year age-groups.
Table 2 Weighted prevalence (95% CI) of respiratory symptoms, obstructive pulmonary disease and common
comorbidities.
Men Women Total
Any daily Cough* 23.6 (20.4–26.7) 17.5 (14.2–20.2) 19.7 (17.7–21.8)
Chronic phlegm* 14.6 (11.9–17.3) 6.9 (5.0–8.9) 9.8 (8.2–11.4)
Wheeze most days or nights (ATS 10.3) 10.3 (8.0–12.5) 6.2 (4.4–8.0) 7.7 (6.3–9.1)
Dyspnea grade 3 or more (ATS 13c) 10.1 (7.9–12.4) 13.7 (10.8–16.5) 12.4 (10.4–14.4)
Unable to walk (ATS 12) 15.4 (13.0–17.9) 23.1 (20.1–26.2) 20.3 (18.2–22.4)
Current doctors dx asthma 8.1 (6.0–10.2) 8.0 (5.9–10.0) 8.0 (6.5–9.5)
Current doctors dx chronic bronchitis 4.7 (3.1–6.3) 3.6 (2.2–5.0) 4.0 (3.0–5.1)
Doctors dx emphysema 6.1 (4.2–7.9) 2.8 (1.5–4.1) 4.0 (2.9–5.1)
At least one OPD 13.4 (10.9–15.9) 9.3 (7.2–11.4) 10.8 (9.2–12.5)
Heart disease treated* 34.2 (30.7–37.8) 25.9 (22.6–29.1) 29.0 (26.5–31.4)
Hypertension treated* 35.9 (32.4–39.5) 44.2 (40.6–47.9) 41.2 (38.5–43.8)
Stroke/transitory ischemic attack 12.6 (10.2–14.9) 10.4 (8.1–12.6) 11.2 (9.5–12.8)
Muscle or joint disease 21.2 (18.1–24.2) 38.0 (34.3–41.6) 31.8 (29.2–34.3)
Diabetes mellitus 7.9 (5.8–9.9) 8.6 (6.5–10.8) 8.4 (6.8–9.9)
Any current cancer 8.9 (6.9–10.9) 7.1 (5.2–9.1) 7.8 (6.3–9.2)
Thyroid disorder 1.6 (0.7–2.5) 11.4 (8.9–13.9) 7.8 (6.2–9.4)
*See appendix for definition of variables.
Prevalence of Respiratory Symptoms in the Elderly 189After adjusting for age and smoking habits, the
only sex difference in self-reported respiratory
disorders was related to dyspnea grade 3 and
chronic phlegm (Table 4). Dyspnea was more often
reported by women than men, while chronicphlegm was more often reported by men than
women. For all the disorders, adjusted odds ratios
increased with increasing smoking status, with the
exception of dyspnea grade 3, in which the
adjusted odds ratio fell to a non-significant level
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Figure 2 Frequencies of smoking status for males (a) and females (b) by age in 5-year age-groups.
J.A. Hardie et al.190in current smokers as compared to never-smokers
(Table 4). When number of pack-years replaced
smoking status in the logistic regression model, the
adjusted odds ratios for all the respiratory dis-orders increased by number of pack-years. After
adjusting for pack-years, males were about half as
likely as females to have dyspnea grade 3 (OR 0.57;
95%CI 0.38–0.85), current asthma (OR 0.52; 95%CI
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Table 3 Weighted prevalence estimates of respiratory symptoms and diseases according to sex and smoking
history in the population.
Smoking history Men P Women P
Never- Ex- Current- Never- Ex- Current-
Any daily cough* 14.3 23.3 38.7 o0:001 16.1 16.6 28.3 0.039
Chronic phlegm* 6.8 14.0 28.6 o0:001 4.7 11.7 10.3 0.026
Wheeze most days or night (ATS 10.3) 2.5 11.2 18.4 o0:001 3.8 11.8 7.7 0.009
Dyspnea grade 3 or more (ATS 13c) 5.2 11.8 10.8 0.016 12.1 19.2 10.0 0.066
Unable to walk (ATS 12) 13.6 14.1 22.3 0.051 22.8 21.2 22.8 0.29
Current doctors dx asthma 2.5 9.3 12.2 0.022 4.9 13.2 14.4 0.003
Current doctors dx chronic bronchitis 0.6 5.2 8.9 0.006 2.1 5.6 8.1 0.013
Doctors dx emphysema 0.7 7.5 8.6 0.006 2.0 3.6 6.1 0.42
At least one OPD 3.0 15.3 22.1 o0:001 5.6 14.8 19.3 o0:001
Prevalence estimates are weighted to the age- and sex-makeup of the population within in each smoking history category. P-
values have been derived from logistic regression analysis separately for each sex, after adjusting for age, and represent the
significance for the smoking variable (as a whole) as a predictor of the various outcome variables.
*See appendix for definition of variables.
Table 4 Odds ratios (95% CI) for gender and smoking status as predictor of respiratory symptoms and disease in
a multivariate model.
Odds Ratio (95% CI) Male gender Smoking history
(versus female) (versus never-smoker)
Ex-smoker Current-smoker
Any daily cough* 1.23 (0.93–1.62) 1.31 (0.97–1.77) 2.55 (1.76–3.70)
Chronic phlegm* 1.60 (1.09–2.35) 1.89 (1.23–2.91) 3.64 (2.21–6.00)
Wheeze most days 1.13 (0.75–1.72) 2.76 (1.69–4.52) 3.91 (2.20–6.95)
Dyspnea grade 3 or more 0.58 (0.39–0.85) 2.16 (1.42–3.27) 1.47 (0.81–2.68)
Current asthma 0.65 (0.43–0.99) 2.54 (1.55–4.15) 3.31 (1.83–5.98)
Current chronic bronchitis 0.84 (0.48–1.47) 3.36 (1.65–6.84) 6.30 (2.88–13.82)
Ever emphysema 1.47 (0.81–2.65) 3.10 (1.52–6.35) 5.44 (2.44–12.13)
At least one OPD 0.96 (0.67–1.37) 2.90 (1.90–4.42) 4.59 (2.81–7.50)
Results from a logistic regression model having entered age (as a continuous variable), sex, and smoking history.
*See appendix for definition of variables.
Prevalence of Respiratory Symptoms in the Elderly 1910.32–0.84), or current chronic bronchitis (OR 0.45;
95%CI 0.23–0.89). There were no significant first- or
second-order interactions in these models. Specifi-
cally, there were no significant interactions be-
tween sex and pack-years, such that we find no
evidence for varying susceptibility for smoking
between the sexes.
Persons with OPD reported problems with walk-
ing, heart disease, and muscle/joint disease more
frequently (Table 5) than those without OPD.
Frequencies of all other reported comorbidities
did not vary significantly by OPD status. The
frequency of two or more comorbidities was higher
in subjects reporting OPD (47.5% versus 37.5%;
P ¼ 0:015). In a multivariate logistic regression,adjusting for sex and smoking history (age fell out
as not significant), reporting at least one OPD was a
significant, independent predictor of reporting
heart disease (OR 1.52; 95%CI 1.08–2.12).Discussion
This study estimated the population prevalence of
smoking, respiratory symptoms, and obstructive
pulmonary diseases based on a large sample of
persons aged 70 years and above. Though similar
data for the elderly were previously available, the
strength of the present study lies in the study
ARTICLE IN PRESS
Table 5 Frequency of self-reported comorbidities in the sample by reported OPD status.
% Persons with OPD Persons without OPD P
Unable to walk 33.9 22.2 0.001
Heart disease 39.1 29.7 0.014
Muscle/joint disease 38.7 28.9 0.011
Hypertension 36.6 38.1 0.74
Thyroid disorder 7.7 5.8 0.37
Any cancer 12.4 8.3 0.10
Diabetes 9.9 7.8 0.36
Stroke (or TIA*) 13.7 13.2 0.81
Result represent unweighted frequencies in the final sample.
*Transitory ischemic attack.
J.A. Hardie et al.192sample, which was drawn directly from the general
population and described in detail in terms of age
trends and sex differences. Some of the patterns of
associations noted in this study may seem para-
doxical and are unquestionably influenced in part
by survivorship effects. It is nonetheless important
to understand the patterns that exist in the very
oldest age groups of our society, especially since
they represent one of the fastest-growing segments
of our population. Also, the general concordance of
our findings with those from the Cardiovascular
Health Study (CHS) and other studies of similarly
aged cohorts suggests that these are real, and not
aberrant, findings.
There was a large portion of the sample (44%)
that did not answer the questionnaire and, as such,
it is possible that our results may be affected by a
non-responder bias. In a separate paper we have
analyzed the differences between early respon-
ders, late responders, and non-responders.10 In
addition to being older and more often female, the
non-responders more often resided in nursing
homes (26% as compared to 5.9% of the responders)
and possibly more often were current smokers (18%
as compared to 12.4% of the responders; non-
significant). There was also a non-significant trend
towards lower frequency of chronic cough and
phlegm in non-responders. Thus we may suspect
that non-responders might slightly more often be
asymptomatic, current smokers. In multivariate
analyses, first with only early responders and then
including all responders, there were no significant
differences in the odds ratios for sex, age, or
smoking history in predicting emphysema, chronic
cough, or chronic phlegm. With regards to the topic
of the current study, all found differences between
responders and non-responders were small and
would have only minimal effects on the final
prevalence estimates for respiratory symptoms
and disease.The prevalence of respiratory symptoms and self-
reported pulmonary disease from this study are
similar to those in the relatively few other studies
in this age group.3–6 The use of different ques-
tionnaires in other studies can make direct com-
parison difficult or impossible, however. Enright4
reports a 10.1% prevalence of dyspnea grade 3 and
a 5.6% prevalence of wheeze most days and nights
in the elderly of the CHS. These are results that are
just slightly lower than our own for the identical
questions (12.4% and 7.7%, respectively), based on
the ATS/DLD questionnaire.
The prevalence of chronic phlegm in our study
was 9.7% which is higher than in a previous study
from rural Norway (5%) but lower than studies from
the United States (13.1%) and England (16.2%),
likely reflecting the difference in reported smoking
histories and in levels of environmental pollution
during the lifetime of these age cohorts.3,4,6,11
It is difficult to know the accuracy of the self-
reported diagnosis in a questionnaire study, espe-
cially in this age group, where many of the
participants may have some recall bias and where
the diagnosis has not been validated by spirometry.
Even when the subject remembers exactly what the
doctor told him or her, a doctor’s choice of disease
label will likely vary with the degree to which the
patient is expected to comprehend the message. In
Norway at the time of the study, there had not been
a name for ‘‘chronic obstructive pulmonary dis-
ease’’ that was familiar to the general population
and other more familiar disease labels such as
asthma or emphysema may have been used as
substitutes to explain the condition to a patient.
The fact that the reported OPD diagnoses overlap
to the degree found may be due to ‘‘disease
labeling’’ confusion. For these reasons, prevalence
of ‘‘at least one OPD’’ seems to be the best term for
external comparison. Mannino5 reports the preva-
lence of at least one OPD at about 12% for the age
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(estimated from published figure), which is similar
to our results of about 11.5% and 9%, respectively.
Our results are also roughly comparable to those of
Isoaho in the population 68 years and over in Lieto,
Finland where the male and female prevalence of
COPD was 12.5% and 3.0% and of Asthma was 2.9%
and 3.8%, respectively.12,13
We found dyspnea grade 3 to be more prevalent
in the female population. This held true also in the
multivariate analysis adjusting for age, and smok-
ing history and/or pack-years, and the association
was not changed significantly after adding body
mass index (self-reported, weight divided by
height-squared: data not shown). Our finding
agrees with other published results, although the
reason for the greater prevalence in women than
men is unresolved.14 Sorlie15 found that for persons
over 70 years old, dyspnea was a significant
predictor of 10-year mortality in men but not in
women. Welle16 showed that dyspnea grade 3 was
inversely related to percent-predicted transfer
factor for carbon monoxide in males but not in
females. Thus, dyspnea in males appears to be a
more clinically significant sign than in females.
Of the symptoms and self-reported diagnoses
that we have studied, only dyspnea shows a
significant relation to age among our subjects. This
may seem to contradict our immediate expectation
to find symptoms and disease increasing by age.
Though previous studies of the elderly have not
reported the frequency of respiratory symptoms by
age, studies that have looked at a wider spectrum
of ages have generally found that respiratory
symptoms are more frequent in the oldest
ages.6,17–20 In these different studies, the symptom
that seems most consistently to increase with age is
dyspnea.
In our data, the prevalence of dyspnea peaks in
the 85–89 age group. This may be a result of simple
non-responder bias. The oldest subjects were the
poorest responders in this study, and it may be the
case that dyspnea was associated with non-
response. An alternate explanation is a survival
selection in the population: persons who survive
into their late 1980s and 1990s were the healthiest
when younger, and the incidence of new onset
dyspnea cannot keep up with the mortality asso-
ciated with established dyspnea. Put in another
way, those that have dyspnea die sooner, and those
who do not have dyspnea do not get it later. This is
supported by studies that have found dyspnea of
any grade to be a significant, independent pre-
dictor of mortality.15,21
Smoking histories vary greatly by both sex and
age group, and our data are in close agreementwith previous smoking data from Norway.8 All of the
respiratory symptoms and OPD increased by smok-
ing status and pack-years except dyspnea, which is
most frequent in ex-smokers rather than in current
smokers. Having dyspnea may convince smokers to
quit smoking.
We know of only one previous study describing
the presence of comorbidities in elderly persons
with OPD. Van Manen and colleagues recently
showed that diseases of locomotor function and
cancer are more prevalent in persons with OPD.7
They did not find the same result for heart disease.
In our study, heart disease and muscle/joint disease
were shown to be more frequent in subjects with
OPD. In a multivariate logistic regression adjusting
for sex and smoking history, OPD showed itself as an
independent predictor of heart disease. Though
labeling confusion and mis-diagnosis of COPD as
heart disease may explain some of this association,
the reasons for these associations are otherwise
unknown. In any case they show that comorbidities
must be taken into account when attempting to
determine the burden of disease in OPD patients.
These comorbidities are more prevalent in persons
with OPD than in the elderly population in general.
One would also suspect that persons with OPD
(especially those with COPD) would be at increased
risk of various cancers. This is not shown in our
results, likely as a result of the high mortality in
these patients.
In conclusion, about 11% of the elderly Bergen
population reported having at least one current
obstructive pulmonary disease, about 8% report
daily wheezing, and 12% reported dyspnea grade 3.
These are results that are similar to those found in
the same age groups in the United States.4,5 Though
these prevalence rates were higher than those
found in younger populations, there was no
association with age within this age group with
the exception of dyspnea, which increased with age
up to the 85–89 age group. Males and females over
70 have very different smoking histories, which to a
large degree explains the variations in respiratory
symptom and disease prevalence. The number of
comorbidities was higher in those who reported
having obstructive pulmonary disease, which leads
us to conclude that comorbidities should be
evaluated when attempting to determine the total
disease burden of persons with OPD.Acknowledgements
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Questionnaire wordingATS-DLD 78 questions Question wording:Any daily cough ‘‘Do you usually have a cough?’’ or ‘‘Do you usually cough in the
morning?’’ or ‘‘Do you usually cough at all during the rest of the day or
night?’’ (ATS 7a or c or d)Chronic phlegm ‘‘Do you usually bring up phlegm from your chest?’’ and ‘‘Do you bring up
phlegm like this on most days for 3 consecutive months or more during
the year?’’ and ‘‘For how many years have you had trouble with
phlegm?’’ (ATS [8a or c or d] and e and f4 ¼ 2),Wheeze ‘‘Does your chest ever sound wheezy or whistling . . . most days or
nights?’’ (ATS 10a.3)Dyspnea grade 3 ‘‘Do you ever have to stop for breath when walking at your own pace on
the level?’’ (ATS 13c)Unable to walk ‘‘Are you disabled from walking by any condition other than heart or lung
disease?’’ (ATS 12),Current doctor-diag-
nosed asthma‘‘Have you ever had asthma?’’ and ‘‘Do you still have it?’’ and ‘‘Was it
confirmed by a doctor?’’ (ATS 20b and c),Current doctor-diag-
nosed chronic bronchitis‘‘Have you ever had chronic bronchitis?’’ and ‘‘Do you still have it?’’ and
‘‘Was it confirmed by a doctor?’’ (ATS 18b and c)Ever doctor-diagnosed
emphysema‘‘Have you ever had emphysema?’’ and ‘‘Was it confirmed by a doctor?’’
(ATS 19c)Treated for heart dis-
ease‘‘Have you ever had treatment for heart trouble in the past 10 years?’’
(ATS 22b)Treated for high blood
pressure‘‘Have you ever had treatment for high blood pressure in the past 10
years?’’(ATS 23b)Supplemental questions on Comorbid conditions (not from ATS-DLD 78 questionnaire):Stroke Have you ever had a stroke?
Muscle/joint disease Do you have muscle disease? or Do you have joint disease?
Diabetes Do you have diabetes?
Any cancer Do you have any cancer?
Thyroid disease Do you have thyroid disease?For the purpose of analysis, the questions on muscle and joint disease were combined into one variable defined as positive if
either question (or both) was answered positive and as negative if both were answered negative. The number of comorbidities
per individual is based on the remaining four conditions, in addition to questions on heart disease and high blood pressure.References
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